These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34082361)

  • 1. Molecular insights into the interaction of angiotensin I-converting enzyme (ACE) inhibitors and HEXXH motif.
    Kircheva N; Dobrev S; Yakimova B; Stoineva I; Angelova S
    Biophys Chem; 2021 Sep; 276():106626. PubMed ID: 34082361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril.
    Kim HM; Shin DR; Yoo OJ; Lee H; Lee JO
    FEBS Lett; 2003 Mar; 538(1-3):65-70. PubMed ID: 12633854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme.
    Pina AS; Roque AC
    J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
    Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
    Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
    Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
    Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachin derived peptides as selective angiotensin I-converting enzyme (ACE) inhibitors: structure-activity relationship.
    Jimsheena VK; Gowda LR
    Peptides; 2010 Jun; 31(6):1165-76. PubMed ID: 20214946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors.
    Chamata Y; Watson KA; Jauregi P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.
    Fernandez M; Liu X; Wouters MA; Heyberger S; Husain A
    J Biol Chem; 2001 Feb; 276(7):4998-5004. PubMed ID: 11067854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Angiotensin Converting Enzyme Inhibitors from Moringa oleifera.
    Khan H; Jaiswal V; Kulshreshtha S; Khan A
    Recent Pat Biotechnol; 2019; 13(3):239-248. PubMed ID: 30747089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
    Natesh R; Schwager SL; Sturrock ED; Acharya KR
    Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP.
    Gregory KS; Cozier GE; Schwager SLU; Sturrock ED; Acharya KR
    FEBS Lett; 2024 Jan; 598(2):242-251. PubMed ID: 37904282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
    Ehlers MR; Riordan JF
    Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico identification of milk antihypertensive di- and tripeptides involved in angiotensin I-converting enzyme inhibitory activity.
    Vukic VR; Vukic DV; Milanovic SD; Ilicic MD; Kanuric KG; Johnson MS
    Nutr Res; 2017 Oct; 46():22-30. PubMed ID: 29173648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.
    Masuyer G; Akif M; Czarny B; Beau F; Schwager SL; Sturrock ED; Isaac RE; Dive V; Acharya KR
    FEBS J; 2014 Feb; 281(3):943-56. PubMed ID: 24289879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an angiotensin-I-converting enzyme inhibitory peptide from tilapia (Oreochromis niloticus) with captopril: inhibition kinetics, in vivo effect, simulated gastrointestinal digestion and a molecular docking study.
    Chen J; Ryu B; Zhang Y; Liang P; Li C; Zhou C; Yang P; Hong P; Qian ZJ
    J Sci Food Agric; 2020 Jan; 100(1):315-324. PubMed ID: 31525262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
    Binevski PV; Sizova EA; Pozdnev VF; Kost OA
    FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.
    Lubbe L; Sewell BT; Sturrock ED
    FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.